Unlocking Q2 Potential of Ventas (VTR): Exploring Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Ventas (VTR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

Zacks Investment Research • 19 hours ago

What's in the Offing for Ventas Stock This Earnings Season?

VTR is expected to have posted higher Q2 revenues and FFO as senior housing demand and OM&R gains offset pressure from triple-net properties.

Zacks Investment Research • Jul 23, 2026

The REIT Recovery Broadens Beyond Rates

As REIT earnings season kicks into gear this week, we preview results and major sector trends based on recent operating indicators, company commentary, and real estate market data. REITs enter earnings season with solid momentum, outperforming the market despite elevated Treasury yields and geopolitical volatility, as investors refocus on earnings growth, property fundamentals, dividends, M&A, and capital allocation. Encouraging green shoots have become more plentiful, including resilient hotel demand, robust senior housing growth, improving apartment and industrial fundamentals, and a rebound in retail leasing following a softer Q1.

Seeking Alpha • Jul 22, 2026

Buy The Dip: 2 REITs Getting Way Too Cheap

Most REITs rallied, but rare bargains still dipped. Major transformations are creating overlooked upside. 5%+ yields offer income while waiting for recovery.

Seeking Alpha • Jul 16, 2026

Ventas (VTR) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?

Zacks Investment Research • Jul 15, 2026

Ventas: Ahead Of Q2 Results, Lots To Like About This Senior-Care REIT

Ventas is positioned as both a dividend and growth REIT, benefiting from macro tailwinds in senior housing demand. VTR's investment-grade balance sheet, geographic diversity, and expanding portfolio underpin its resilience and modest growth outlook. Despite a rich 23x forward earnings multiple, upside forecasts are only 7%–10%, warranting a more neutral valuation stance.

Seeking Alpha • Jul 12, 2026

Equity REITs: Takeaways From REITWeek 2026

REITs are poised for 6-7% earnings growth in coming years, outpacing the historical 3-4% average, with multiple sectors showing accelerating fundamentals. Shopping centers, healthcare (notably senior housing), and data centers are standout sectors, benefiting from robust private market demand, supply constraints, and AI-driven tailwinds. Office REITs see improving leasing, especially from AI-related demand, while quality bifurcation widens; overweight positions in BXP and CUZ reflect this thesis.

Seeking Alpha • Jul 5, 2026

Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its second quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 29, 2026. A conference call to discuss those earnings will be held on Thursday, July 30, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can b.

Business Wire • Jun 29, 2026

Is Holding Ventas Stock Still a Smart Move for Your Portfolio Now?

VTR benefits from strong senior housing demand, rising occupancy and solid liquidity but faces competition, tenant concentration and high debt.

Zacks Investment Research • Jun 25, 2026

Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that the Company has named Andrew L. Wattula Executive Vice President, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, a wholly-owned property management and leasing subsidiary of Ventas, effective August 2026. He will oversee the Company's differentiated outpatient medical and research business, which is a leading owner and manager of properties operating at the intersec.

Business Wire • Jun 22, 2026